Mycoplasma Testing Market Outlook 2024: Exclusive Report By The Business Research Company

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Mycoplasma Testing Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The mycoplasma testing market size has grown rapidly in recent years. It will grow from $0.94 billion in 2023 to $1.08 billion in 2024 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to outbreaks and contamination incidents, increased awareness, biotechnology sector expansion, research and development initiatives, healthcare industry trends, rise in cell culture production.

The mycoplasma testing market size is expected to see rapid growth in the next few years. It will grow to $1.71 billion in 2028 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to demand for quality assurance, emerging market demand, biopharmaceutical industry growth, rise in cell-based therapies, expansion of biotechnology sector. Major trends in the forecast period include regulatory standards and compliance, healthcare awareness and diagnostics, global pandemic preparedness, point-of-care testing innovation, market penetration in emerging economies.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=4103&type=smp

Market Segmentation:
The mycoplasma testing market covered in this report is segmented -

1) By Product: Instruments, Assay, Kits, and Reagents
2) By Technology: PCR, ELISA, Enzymatic Methods, DNA Staining, Other Technologies
3) By Application: Cell line Testing, Virus Testing, End- of- Production Cell Testing
4) By End User: Pharmaceutical & Biotechnology Companies, Cell Banks & Laboratories, Contract Research Organizations, Academic Research Institutes

Major Driver - Rising Incidence Of Mycoplasma Pneumonia Fuels Growth In Mycoplasma Testing Market
The increasing prevalence of mycoplasma pneumonia is expected to propel the growth of the mycoplasma testing market going forward. Mycoplasma pneumonia refers to a respiratory infection caused by the bacteria Mycoplasma pneumoniae. Mycoplasma testing plays a crucial role in diagnosing Mycoplasma pneumonia by detecting the presence of Mycoplasma pneumoniae bacteria in respiratory specimens, aiding in the timely and accurate identification of the infection for appropriate medical treatment and management. For instance, in December 2023, according to the Centers for Disease Control and Prevention, a US-based government agency An estimated 2 million cases of Mycoplasma pneumoniae infections occur each year in the United States. Therefore, the increasing prevalence of mycoplasma pneumonia is driving the growth of the mycoplasma testing market.

Competitive Landscape:
Major companies operating in the mycoplasma testing market report are Abbott Laboratories, Merck KGaA, Thermo Fisher Scientific Inc., Boston Scientific Corporation, Olympus Corporation, Agilent Technologies Inc., Lonza Group AG, Roche Diagnostics International AG, Smith & Nephew plc, Charles River Laboratories International Inc., CONMED Corporation, Nelson Laboratories Fairfield Inc., AngioDynamics Inc., Creative Bioarray, Biological Industries Israel Beit Haemek Ltd., Biotools B & M Labs S.A, PromoCell GmbH, American Type Culture Collection, Bionique Testing Laboratories Inc., InvivoGen, Clongen Laboratories LLC, Norgen Biotek Corporation, Gen Bio Sciences (P) Ltd., GeneCopoeia Inc., Minerva Biolabs GmbH, Mycoplasma Experience, Savyon Diagnostics, ScienCell Research Laboratories Inc., AtriCure Inc., Advanced Cardiac Therapeutics Inc., ARTWORKSIT

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Top Trend - Digital PCR Kits Transform Mycoplasma Testing Market
Major companies operating in the mycoplasma testing market are increasing their focus on introducing digital PCR kits to gain a competitive edge in the market. Digital PCR kits refer to molecular biology tools that enable the precise quantification and analysis of nucleic acids, such as DNA or RNA, by using a digital approach. For instance, in November 2023, QIAGEN, a Germany-based diagnostics company, launched three new QIAcuity digital PCR kits and updated software to expand the use of digital PCR applications in biopharmaceutical research and food safety. The new QIAcuity kits are designed to ensure precise quantification and are available in one, four, and eight-plate versions, with the one-plate version capable of processing up to 384 samples in an eight-hour shift. The QIAcuity Mycoplasma Quant Kit is one of the new kits launched, and it offers researchers an accurate and precise way to detect mycoplasma contaminants in all steps of research.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Mycoplasma Testing Market Characteristics
3. Mycoplasma Testing Market Trends And Strategies
4. Mycoplasma Testing Market - Macro Economic Scenario
5. Mycoplasma Testing Market Size And Growth
…..
27. Mycoplasma Testing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.